You Are Here: Home > Get Involved > Participate > Find an Event Near You > Canadian Arthritis Research Conference: Research with Impact
Go Back to Events

Canadian Arthritis Research Conference: Research with Impact

 
photo to supplement event

February 07, 2022


Virtual Event

Canadian Arthritis Research Conference

The Arthritis Society (AS), Canadian Rheumatology Association (CRA), and CIHR-IMHA are proud to co-host the third annual Canadian Arthritis Research Conference (CARC), virtually on February 7-8, 2022. This conference will feature a range of presentations, discussions, and networking opportunities with experts, researchers, consumers, and emerging leaders from the arthritis community.

Important Dates and Details

[Keynotes & Symposia]:

Feb 7, 2022 - 11:40 – 16:30 ET
Feb 8, 2022 – 11:55 – 16:30 ET

Join us for 2 keynotes, 12 invited symposia, and 12 ‘Best Research’ presentations by researchers at all career stages. These 12 ‘Best Research’ presentations will come from the call of abstracts competition (see below).

[Research Presentation Day]:

January 31, 2022

In addition to the conference, the second annual Research Presentation Day provides a public platform for researchers to present their research to a wide audience, including systematic reviews, all types of original research, and evidence synthesis. There will be expert tips for early career scientists (including clinicians) and opportunities for breakout groups. The top 12 research presentations from this day will be awarded spots to present at CARC on February 7-8, 2022.

Why attend CARC?

  • Networking opportunities! It provides all levels of trainees and researchers (clinical fellows and MSc/PhD/Postdoc/Medical Residents/etc.) to present and engage with researchers, clinicians, and other experts in the field.
  • Monetary prizes will be awarded for winning research abstracts relating to posters and presentations made for CARC.
  • Keynote and symposia presenters will be provided honoraria to reflect their preparation and contribution to the conference.

Who should consider attending?

The world of arthritis researchers, clinicians, patients, and trainees. This conference (and its predecessor, the CAN Network Meetings of the early 2000s) have traditionally been well attended by rehabilitation researchers, other clinicians, basic scientists and health systems researchers. Abstracts are welcome from across all areas relating to arthritis. Email us if you are not sure you fit (but you will!). 

Call to action

  1. Hold the 2022 dates: CARC Keynotes & Symposia: February 7 & 8, 2022.
  2. Keep January 31, 2022 free to present your research abstract, if selected.
  3. Details on how to submit abstracts, register for the conference will be updated here soon.

Crowdsourcing Call

In keeping with equity principles, open science, and the wisdom of crowds, we invite you to submit applications for keynote speakers and symposia for February 7 -8, 2022.

We are inviting submissions for 20-minute keynote addresses (two individuals) and 90-minute symposia (3-speaker panel). Given that CARC 2022 will be virtual there is an opportunity to have a mix of national and international speakers. All speakers must be available to present (virtually) on February 7-8, 2022 between 11:40 am and 16:30 pm ET.

Submissions will be evaluated by the CARC Scientific Committee. Selection criteria include the importance and impact of the topic, stakeholder involvement, principles of equity, diversity, inclusivity and Indigenous rights, and in the case of symposia, a panel comprised of multiple disciplines.

Guidelines for applications   Crowdsourcing Sample Proposal   Submit applications

All applications must be received by August 31, 2021, 11:59 pm ET.

Call for Abstracts

The Arthritis Society, Canadian Rheumatology Association and the Canadian Institutes of Health Research-Institute of Musculoskeletal Heath and Arthritis invite you to submit abstracts for presentation at the third annual Canadian Arthritis Research Conference (CARC). Participants of all career stages, including but not limited to, faculty members, research associates, clinicians, trainees of all levels, and consumers/patient partners are encouraged to submit abstracts.  

We encourage biomedical, clinical, health systems and population health research in the broad field area of arthritis. This is an opportunity to share your work with colleagues nationally and internationally.

 If your abstract is accepted, you will be invited to present your research through either one or both of the following two opportunities depending on your preference:

  1. An oral presentation at Research Presentation Day to be held virtually on January 31, 2022 (See Prizes section below).
  2. A Poster presentation held virtually during the keynote and symposia poster session to be held on February 7-8, 2022.

Submit Abstract

  • Important Dates

    October 4, 2021: All abstracts (for both oral presentations and posters) must be submitted via this webform before 13:00 ET on October 4, 2021. Late submissions will not be accepted. Authors will receive an email confirming the receipt of their submission. Conference registration ($25 early bird, $50 late registration) is a pre-requisite for participating in Research Presentation Day and CARC Poster Session. Registration will open in November 2021.  

    October 18, 2021: Authors will receive decision emails from the CARC Scientific Committee via imha-iala@cihr-irsc.gc.ca. All those who choose to present at the research presentation day on January 31, 2021 should also set aside time in their calendars for possible selection for a CARC presentation on February 7-8, 11:40 -16:30 ET.

    January 31, 2022 - Research Presentation Day: Speakers will present a seven-minute oral presentation of their work via Zoom webinar. There will be a two-minute Q&A period.  The top 12 ranked presenters, as determined by the Scientific Committee, will be invited to present in the CARC keynote and symposia days on February 7 and 8, 2022 (11:40 -16:30 ET), and be awarded a monetary prize. Evaluation criteria will be provided to all participants.

    February 7 & 8 – Keynote & Symposia. Selected speakers (as chosen through the Research Presentation Day) will be invited to speak at the two-day event. These virtual events will feature a range of presentations, discussions, and networking opportunities with experts, researchers, consumers and emerging leaders in the field of arthritis. Poster session participants will have the opportunity to present their research at selected times and discuss with leading experts in the field.

  • Addressing Equity, Diversity and Inclusion, and Indigenous Rights

    CARC aims to implement and champion principles of equity, diversity and inclusion, and foster Indigenous rights, within our scientific content and selection criteria. CARC welcomes a diverse community to submit abstracts/symposia and attend our conference, including people from communities that have historically been marginalized and underrepresented. We will keep a particular focus on patients, Indigenous peoples, and other health consumers. We encourage submissions that address or discuss concepts relevant to the arthritis community and equity, diversity, inclusion, and Indigenous rights.

  • Submissions

    We welcome submissions from participants of all career stages, including but not limited to, faculty members, research associates, clinicians, all levels of trainees, and students. Consumers/patient partners are also encouraged to submit.

    We encourage biomedical, clinical, health systems and population health research in the broad field area of arthritis.

    Please note that abstracts that have been submitted to the 2022 Canadian Rheumatology Association and Arthritis Health Professionals Association Annual Scientific Meeting are not eligible for submission at CARC 2022 (keynote and symposia, and research presentation day).

  • Prizes

    The top 12 ranked presenters from the Research Presentation Day will be selected to present at the keynote and symposia on February 7-8, 2022. The scientific committee aims to feature at least 50% trainee presentations from undergraduate, master’s students, and PhD candidates. All winners will be expected to deliver a ten-minute presentation followed by a five-minute Q&A period. Please note that the time limit allotted for Feb 7-8 presentations is longer than Research Presentation Day.

  • Requirements

    All submissions must include:

    • A scholarly abstract of no more than 400 words in English or 500 words in French  
    • A title
    • A list of all authors using their full names and including their current email address
    • Institution affiliations where applicable and ‘N/A’ for authors based outside institutions
    • Disclosure of any conflicts of interest (also called ‘competing interests’. If none, write “N/A”)
    • Note: All accepted abstracts will be made available to conference attendees. They will also be posted on the CARC website.  

    We recommend you use the following subheadings: [not obligatory]

    • Background/Aims
    • Methods
    • Results
    • Discussion/Conclusion
    • Take home message (one line)
    • Funding acknowledgement (this does not contribute to the word count)
    • Declaration of interest (this does not contribute to the word count)

    Poster Details

    For this virtual conference, posters must fit onto a PDF page. Specific details will be shared in the email that will be sent to successful applicants on October 18.

  • Help for Patient Partners to Submit an Abstract

    The link to an infographic below aims to give you a basic understanding of the concept of abstracts, how they relate to conferences, and how they are usually structured. Our hope is that this information helps you develop and submit your own abstract to the CARC conference. Abstracts are open to anyone who wishes to submit one.

    Abstract Basics

    The Basics about Conference (and Other) Abstracts  

    If you’re a patient partner, the concept of a conference abstract might be new. Here we’ve put together a basic overview of what an abstract is, its purpose, and the typical parts to help you co-create or write and submit an abstract. This was developed with input from a number of people who are acknowledged below. 

    Conferences provide instructions about the abstract format or there is an online submission form with instructions. A typical abstract format with basic parts (may depend on the conference) is shown below. 

    Share your draft abstract with co-authors for their input and to declare their conflicts - well in advance of the deadline. Provide a copy of the submitted abstract to your co-authors for their files. 

    The conference organizers might give you an idea of when to expect a decision on your abstract. 

    Good luck with your abstract! We hope you have found this to be helpful and informative! 

    What is an ‘abstract’ is and its purpose? 

    • A brief summary of research or work you have done or will do before a conference to present at a conference (the work doesn’t have to be completed yet(!), but the goal is for it to be done by the conference).  
    • Submitted to conference organizers a few months before a conference to ‘apply’ to present your research at a conference.  
    • Typical presentation types you can request: 
      • Poster: Develop a poster of your research and present it; you are given a time to present and answer questions about your poster (in person or virtual conference) 
      • Oral: Present on your own, with a co-author, or as part of a panel about a similar topic; length of time can vary  
      • Workshop – Host a workshop, often with others. 
    • The abstract is ‘reviewed’ by a committee. If accepted, you will be told the presentation type you are invited to give based on your preference when you applied.  
    • Anyone can write an abstract. Patient partners often help prepare the abstract or may write and submit one on their own. 
    • A way to share knowledge. The abstract is often part of an ‘abstract book’ given to conference attendees or in a journal that accompanies the conference. 

    Parts of an Abstract 

    • Title of your presentation 
    • Authors. Contributors to the work and their affiliations (often ordered from who contributed the most to the least). Patient partners may or may not have an affiliation – hopefully the submission allows for flexibility. A ‘presenting author’ is the person who will present the work if accepted.  
    • The main body. Instructions about sections or headings, word count, and anything else required. Generally, the main parts are: 
      • The goal or objective. Why you did the research and what you hoped to accomplish 
      • A bit of background. Why the goal is important (e.g. an area that patients have indicated is an unmet need). 
      • How the research was done or methods and approaches. For example, was there a review of the scientific literature or current knowledge? Was a survey done (and if so, how many people responded?)? Were there focus groups? Were patient partners part of the team, and if so, how were they involved? 
      • Results and discussion. Highlights of the findings and why you found them interesting or maybe the findings weren’t what you expected and you can share those and your thoughts. 
      • Conclusion or summary. The ‘takeaway’ or one or two things that you found and want people to remember. 
    • Potential conflicts of interest. Any relationships that may be perceived to influence the research and important for transparency (e.g. employment, a consultancy, being provided an honorarium, relationships with for profit companies, etc.).  

    Information Credit: The aforementioned information to help patient partners was put together through a crowdsourcing call put out by Dr. Dawn Richards through her Twitter handle @TO_dpr. The call was open to anyone to provide input.

    Thank you for your input: Brenda Andreas, Mary Brachaniec, Rachel Cooper, Jennifer Daly-Cyr, Trudy Flynn, Erin Gilmer, Kathy Kastner, Delane Linkiewich, Laurie Proulx, Zal Press, Maureen Smith, Linda Wilhelm, and Andy Wong.

  • Disclosures

    Authors are responsible for reporting any real or perceived competing interests. A brief disclosure and Declaration of Interests statement must be part of the submitted abstract. Any potential for financial gain that may be derived from reported work may constitute a possible competing interest. Disclosure is required in any case in which an individual or company stands to benefit financially from research performed. Therefore, each author must indicate any benefit to an individual or company that may potentially lead to financial reward.

    A “financial interest” may include but is not limited to:

    • being a shareholder
    • receiving research funding or other support
    • receiving fees or other benefits for any role (including speaking at CPD activities)
    • being a paid employee or consultant

    An “affiliation” may include but is not limited to:

    • holding a position in the organization
    • sitting on an advisory committee
    • playing some other role of benefit to the organization

    Disclosures should appear on the bottom left corner of the poster and may follow the recommended format: "Disclosures: None" or "Disclosures: The author(s) disclose a relationship with..."

Scientific Committee
  • Dr. Marie Hudson, Scientific Planning Committee Co-Chair Associate Professor, McGill University, Physician-Scientist, Jewish General Hospital and Lady Davis Institute for medical research, and co-Director, McGill Interdisciplinary Initiative in Infection and Immunity (CRA membership representative)

  • Dr. Dawn Richards, Scientific Planning Committee Co-Chair Volunteer Vice President of the Canadian Arthritis Patient Alliance; Founder of Five02 Labs; Consultant to CIHR-IMHA (Patient representative)

  • Dr. Jackie Whittaker, Scientific Planning Committee Co-Chair Assistant Professor in the Faculty of Medicine at University of British Columbia, Research Scientist at Arthritis Research Canada, and Michael Smith Foundation for Health Research Scholar  

  • Dr. Tom Appleton, Hospital Chief of Rheumatology at SJHC London, Assistant Professor in the Departments of Medicine and Physiology and Pharmacology and the Schulich School of Medicine & Dentistry at Western University, and Scientist at Lawson Health Research Institute and the Children's Health Research Institute

  • Dr. Sian Bevan, Chief Science Officer, Arthritis Society

  • Dr. David Hart, Professor in the Department of Surgery and Faculty of Kinesiology at the University of Calgary, and Member of the McCaig Institute for Bone & Joint Health, Scientific Director of the Alberta Health Services Bone & Joint Health Strategic Clinical Network

  • Dr. Mohit Kapoor, Professor in the Department of Surgery and the Department of Laboratory Medicine and Pathobiology at University of Toronto, Co-Director of the Schroeder Arthritis Institute and Senior Scientist at the Krembil Research Institute, Tony and Shari Fell Platinum Chair in Arthritis Research and Tier 1 Canada Research Chair in the mechanisms of joint degradation.

  • Dr. Karim Khan, Professor in the Department of Family Practice and School of Kinesiology at University of British Columbia, and Scientific Director of the Canadian Institutes of Health Research-Institute of Musculoskeletal Health and Arthritis [CIHR-IMHA] 

  • Kyle Vader, Physiotherapist within the Kingston Health Sciences Centre (KHSC) Chronic Pain Clinic, and a PhD Candidate in Rehabilitation Science at Queen’s University (Trainee Representative)

  • CARC 2021

    2021 Virtual Canadian Arthritis Research Conference, February 16 & 17, 2021.

    The second annual Canadian Arthritis Research conference, held on February 16 & 17, 2021, was a first-of-its-kind virtual conference that brought together 180 researchers, clinicians and individuals living with arthritis from across the globe to explore perspectives, advance knowledge and enhance Canadian leadership in the world of arthritis and rheumatic diseases. The conference is co-presented by the Arthritis Society, Canadian Rheumatology Association, and CIHR-IMHA.

    The theme of the two-day conference was “Research with Impact – Nurture Leaders”. CARC 2021 provided two days of quality content relating to both osteoarthritis (OA) and rheumatoid arthritis (RA). In addition to keynote and invited presentations, CARC 2021 provided a forum for investigators to share original research.

    New in 2021 was an Original Research Presentation Day that was held on February 5, 2021. Researchers in all areas of RA and OA were invited to submit an abstract and give a ten-minute presentation over Zoom on their original research to an audience of researchers and people living with arthritis. The Original Research Day was an opportunity to foster collaboration and facilitate knowledge translation among the arthritis research community. Its success was noted by 75 attendees including researchers and senior professionals from both the RA and OA space.

    We want to give a special thanks to the scientific planning committee, for all their contributions to the development of the program. This conference would not have come together without their leadership.

    • Dr. Jackie Whittaker, Assistant Professor in the Faculty of Medicine, University of British Columbia, Research Scientist at Arthritis Research Canada, and Michael Smith Foundation for Health Research Scholar (scientific committee co-chair, and co-chair of the session on rehabilitation, rheumatoid arthritis, and rehabilitation, osteoarthritis);

    • Dr. Marie Hudson, Associate Director for Clinical Research, Lady Davis Institute Assistant Professor at McGill University (CRA membership representative and scientific committee co-chair, and co-chair of the session on medicine, rheumatoid arthritis, and medicine, osteoarthritis);

    • Dr. Dawn Richards, volunteer Vice President of the Canadian Arthritis Patient Alliance (Patient representative, scientific committee co-chair, and co-chair of the session on medicine, rheumatoid arthritis);

    • Dr. Karim Khan, Professor, Department of Family Practice and School of Kinesiology, University of British Columbia, and Scientific Director, Canadian Institutes of Health Research-Institute of Musculoskeletal Health and Arthritis;

    • Dr. Tom Appleton, Hospital Chief of Rheumatology at SJHC London, Assistant Professor in the Departments of Medicine and Physiology and Pharmacology, and Schulich School of Medicine & Dentistry at Western University, and Scientist at Lawson Health Research Institute, and Children's Health Research Institute;

    • Dr. Cheryl Carmelle Marie Barnabe, Associate Professor at the Departments of Medicine and Community Health Sciences, University of Calgary, and Rheumatologist at Alberta Health Services.

  • CARC 2020

    2020 Canadian Arthritis Research Conference, February 25-26, 2020.

    The theme of the first annual conference was “Taking Collaborative Action”. 90 researchers, clinicians and people living with arthritis from across Canada, the United States and the UK came together to explore perspectives, advance knowledge and enhance Canadian leadership in the world of arthritis and rheumatic diseases.  

    The two day-conference saw three distinct sessions with national and international speakers presenting on the following themes:

    1. Living Well: Easing Pain through Research
    2. New Approaches to Inflammation and Tissue Repair
    3. Getting Hooked on Big Data Science

    Each session was anchored by a consumer presentation and was followed by presentations from two trainees, and basic and clinical scientists’ presentations. Through collaborative presentations and group conversations, the presenters collectively highlighted current research and approaches to pain, inflammation and tissue repair, and the integration of open-source data in clinical applications.  

    The CARC Poster session had 28 researchers presenting on their current projects across Canada. The two top poster winners were Dr. Shabana Amanda Ali in the postdoctoral fellow category and Dale Fournier in the graduate student category. Congratulations to both Amanda and Dale!

    We want to give a special thanks to the scientific planning committee, for all their contributions to the development of the program over the last eight months. This conference would not have come together without their leadership.  

    • Dr. Hani El-Gabalawy: Chair of planning committee, Co-chair for Session 1
    • Graeme Reed: Co-chair for Session 1
    • Dr. Jeff Dixon: Co-chair for Session 2
    • Dr. Heinrike Schmeling: Co-chair for Session 2
    • Dr. Shabana Amanda Ali: Co-chair for Session 2
    • Dr. Proton Rahman: Co-chair for Session 3
    • Dr. Diane Lacaille: Co-chair for Session 3
    • Dr. Marie Hudson: Committee Member